Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy

Clinical trial NCT02310867 · RECRUITING

Trial details

NCT number: NCT02310867
Sponsor: Linda Cendales
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Immunosuppression

Start date: 2015-03-01
Primary completion: 2027-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.